112 related articles for article (PubMed ID: 25905517)
1. Development of the Plutonium-DTPA Biokinetic Model.
Konzen K; Brey R
Health Phys; 2015 Jun; 108(6):565-73. PubMed ID: 25905517
[TBL] [Abstract][Full Text] [Related]
2. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy.
Breustedt B; Blanchardon E; Bérard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097
[TBL] [Abstract][Full Text] [Related]
3. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
[TBL] [Abstract][Full Text] [Related]
4. Improved Modeling of Plutonium-DTPA Decorporation.
Dumit S; Avtandilashvili M; Strom DJ; McComish SL; Tabatadze G; Tolmachev SY
Radiat Res; 2019 Feb; 191(2):201-210. PubMed ID: 30566387
[TBL] [Abstract][Full Text] [Related]
5. Plutonium-DTPA Model Application with USTUR Case 0269.
Konzen K; Brey R; Miller S
Health Phys; 2016 Jan; 110(1):59-65. PubMed ID: 26606066
[TBL] [Abstract][Full Text] [Related]
6. Developing a physiologically based approach for modeling plutonium decorporation therapy with DTPA.
Kastl M; Giussani A; Blanchardon E; Breustedt B; Fritsch P; Hoeschen C; Lopez MA
Int J Radiat Biol; 2014 Nov; 90(11):1062-7. PubMed ID: 24844369
[TBL] [Abstract][Full Text] [Related]
7. Circulatory kinetics of intravenously injected 238Pu(IV) citrate and 14C-CaNa3-DTPA in mice: comparison with rat, dog, and reference man.
Durbin PW; Kullgren B; Schmidt CT
Health Phys; 1997 Feb; 72(2):222-35. PubMed ID: 9003707
[TBL] [Abstract][Full Text] [Related]
8. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu.
James AC; Sasser LB; Stuit DB; Glover SE; Carbaugh EH
Radiat Prot Dosimetry; 2007; 127(1-4):449-55. PubMed ID: 18227077
[TBL] [Abstract][Full Text] [Related]
9. Combined drug and surgery treatment of plutonium-contaminated wounds: indications obtained using a rodent model.
Griffiths NM; Coudert S; Wilk JC; Renault D; Angulo JF; Van der Meeren A
Health Phys; 2014 Jun; 106(6):638-44. PubMed ID: 24776894
[TBL] [Abstract][Full Text] [Related]
10. Early blood plutonium retention in nonhuman primates compared to the NCRP 156 wound biokinetic model.
Konzen K; Brey R; Guilmette R
Health Phys; 2015 Mar; 108(3):383-7. PubMed ID: 25627953
[TBL] [Abstract][Full Text] [Related]
11. Interpretation of Urinary Excretion Data From Plutonium Wound Cases Treated With DTPA: Application of Different Models and Approaches.
Poudel D; Bertelli L; Klumpp JA; Waters TL
Health Phys; 2017 Jul; 113(1):30-40. PubMed ID: 28542009
[TBL] [Abstract][Full Text] [Related]
12. Development of a New Chelation Model: Bioassay Data Interpretation and Dose Assessment after Plutonium Intake via Wound and Treatment with DTPA.
Dumit S; Miller G; Klumpp JA; Poudel D; Bertelli L; Waters TL
Health Phys; 2020 Dec; 119(6):715-732. PubMed ID: 33196524
[TBL] [Abstract][Full Text] [Related]
13. Modelling DTPA therapy following Am contamination in rats.
Kastl M; Grémy O; Lamart S; Giussani A; Li WB; Hoeschen C
Radiat Environ Biophys; 2023 Nov; 62(4):483-495. PubMed ID: 37831188
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early treatment with DTPA.
Sérandour AL; Grémy O; Fréchou M; Renault D; Poncy JL; Fritsch P
Radiat Res; 2008 Aug; 170(2):208-15. PubMed ID: 18666819
[TBL] [Abstract][Full Text] [Related]
15. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches.
Fritsch P; Grappin L; Guillermin AM; Fottorino R; Ruffin M; Mièle A
Radiat Prot Dosimetry; 2007; 127(1-4):120-4. PubMed ID: 17562647
[TBL] [Abstract][Full Text] [Related]
16. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
[TBL] [Abstract][Full Text] [Related]
17. Three plutonium chelation cases at Los Alamos National Laboratory.
Bertelli L; Waters TL; Miller G; Gadd MS; Eaton MC; Guilmette RA
Health Phys; 2010 Oct; 99(4):532-8. PubMed ID: 20838095
[TBL] [Abstract][Full Text] [Related]
18. Twenty-four years of follow-up for a Hanford plutonium wound case.
Carbaugh EH; Lynch TP; Antonio CL; Medina-Del Valle F
Health Phys; 2010 Oct; 99(4):483-94. PubMed ID: 20838089
[TBL] [Abstract][Full Text] [Related]
19. Excretion of Pu-238 during Long-term Chelation Therapy by Repeated DTPA Inhalation.
Grémy O; Blanchin N; Miccoli L
Health Phys; 2022 Sep; 123(3):197-207. PubMed ID: 35613373
[TBL] [Abstract][Full Text] [Related]
20. A case of wound intake of plutonium isotopes and 241Am in a human: application and improvement of the NCRP wound model.
Schadilov AE; Belosokhov MV; Levina ES
Health Phys; 2010 Oct; 99(4):560-7. PubMed ID: 20838099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
